ID: ALA99055

Max Phase: Preclinical

Molecular Formula: C23H22F6N4O2

Molecular Weight: 500.44

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): L-741671
Synonyms from Alternative Forms(1):

    Canonical SMILES:  O=c1[nH]nc(CN2CCC[C@H](OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H]2c2ccccc2)[nH]1

    Standard InChI:  InChI=1S/C23H22F6N4O2/c24-22(25,26)16-9-14(10-17(11-16)23(27,28)29)13-35-18-7-4-8-33(12-19-30-21(34)32-31-19)20(18)15-5-2-1-3-6-15/h1-3,5-6,9-11,18,20H,4,7-8,12-13H2,(H2,30,31,32,34)/t18-,20-/m0/s1

    Standard InChI Key:  ZUWHBRRBKKTMQO-ICSRJNTNSA-N

    Associated Targets(Human)

    TACR1 Tclin Neurokinin 1 receptor (6273 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Cavia porcellus (23802 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    Rattus norvegicus (775804 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    Mustela putorius furo (1007 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    Rhesus monkey (3147 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 500.44Molecular Weight (Monoisotopic): 500.1647AlogP: 5.06#Rotatable Bonds: 6
    Polar Surface Area: 74.01Molecular Species: ACIDHBA: 4HBD: 2
    #RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
    CX Acidic pKa: 5.87CX Basic pKa: 7.03CX LogP: 4.21CX LogD: 4.14
    Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.46Np Likeness Score: -0.81

    References

    1. Ladduwahetty T, Baker R, Cascieri MA, Chambers MS, Haworth K, Keown LE, MacIntyre DE, Metzger JM, Owen S, Rycroft W, Sadowski S, Seward EM, Shepheard SL, Swain CJ, Tattersall FD, Watt AP, Williamson DW, Hargreaves RJ..  (1996)  N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists.,  39  (15): [PMID:8709125] [10.1021/jm9506534]
    2. Takeuchi Y, Shands EF, Beusen DD, Marshall GR..  (1998)  Derivation of a three-dimensional pharmacophore model of substance P antagonists bound to the neurokinin-1 receptor.,  41  (19): [PMID:9733486] [10.1021/jm9700171]
    3. Evers A, Klebe G..  (2004)  Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model.,  47  (22): [PMID:15481976] [10.1021/jm0311487]
    4. Wu YJ, Meanwell NA..  (2021)  Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.,  64  (14.0): [PMID:34213340] [10.1021/acs.jmedchem.1c00790]

    Source